Connection

Scott Eblen to Antineoplastic Agents

This is a "connection" page, showing publications Scott Eblen has written about Antineoplastic Agents.
Connection Strength

0.977
  1. Targeting Chromatin Remodeling for Cancer Therapy. Curr Mol Pharmacol. 2019; 12(3):215-229.
    View in: PubMed
    Score: 0.369
  2. Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes. Adv Cancer Res. 2018; 138:99-142.
    View in: PubMed
    Score: 0.348
  3. EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis. 2014 May; 35(5):1100-9.
    View in: PubMed
    Score: 0.261
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.